ARTICLE | Clinical News
Tecentriq regulatory update
January 11, 2017 6:42 PM UTC
FDA accepted and granted Priority Review to an sBLA from Roche’s Genentech unit for Tecentriq atezolizumab to treat locally advanced or metastatic urothelial carcinoma in patients who are ineligible ...
BCIQ Target Profiles